<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Calibri","sans-serif";
        color:windowtext;}
p.clear, li.clear, div.clear
        {mso-style-name:clear;
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
span.bold
        {mso-style-name:bold;}
p.linklisting, li.linklisting, div.linklisting
        {mso-style-name:linklisting;
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
span.pr0
        {mso-style-name:pr0;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-GB link=blue vlink=purple><div class=WordSection1><p class=clear>The deadline for the special issue of Frontiers in Neuroengineering ‘<b>Interaction of BCI with the underlying neurological conditions in patients: pros and cons’</b>, topic editors <span class=bold>Topic Editors: </span><span style='color:black'><a href="http://www.frontiersin.org/Community/WhosWhoActivity.aspx?sname=AleksandraVuckovic&UID=77206"><span style='color:black;text-decoration:none'>Aleksandra Vuckovic</span></a>, <a href="http://www.frontiersin.org/Community/WhosWhoActivity.aspx?sname=JaimePineda&UID=84245"><span style='color:black;text-decoration:none'>Jaime A. Pineda</span></a>, <a href="http://www.frontiersin.org/Community/WhosWhoActivity.aspx?sname=KristenLaMarca&UID=105252"><span style='color:black;text-decoration:none'>Kristen LaMarca</span></a> <a href="http://www.frontiersin.org/Community/WhosWhoActivity.aspx?sname=DishaGupta&UID=105182"><span style='color:black;text-decoration:none'>Disha Gupta</span></a>, <a href="http://www.frontiersin.org/Community/WhosWhoActivity.aspx?sname=ChristophGuger&UID=1735"><span style='color:black;text-decoration:none'>Christoph Guger</span></a>, has been extended until 15<sup>th</sup> December</span><o:p></o:p></p><p class=clear><span style='color:black'><a href="http://www.frontiersin.org/neuroengineering/researchtopics/interaction_of_bci_with_the_un/2020">http://www.frontiersin.org/neuroengineering/researchtopics/interaction_of_bci_with_the_un/2020</a></span><o:p></o:p></p><p class=clear>In this Research Topic we welcome studies of the highest scientific quality highlighting how BCI systems based on different principles (SSVEP, P300, slow cortical potential, auditory potential, operant conditioning, etc) interact with the underlying neurological problems and how performance of these BCI system differ compared to similar systems tested on healthy individuals. We also welcome studies defining signatures of neurological disorders and proposing BCI based treatments. <o:p></o:p></p><p class=clear>We expect to generate a body of knowledge valuable both to researchers working with clinical populations, but also to a vast majority of BCI researchers testing new algorithms on able-bodied people. This should lead towards more robust or tailor-made BCI protocols, facilitating translation of research from laboratories to the end users. <br><br>We are looking for the original work, data supported findings, as well as comprehensive review articles that map out what is and is not possible in this filed in the near and far future.<span style='color:black'><o:p></o:p></span></p><p class=clear><span style='color:black'>On behalf of topic editors<o:p></o:p></span></p><p class=clear><span style='color:black'>Aleksandra Vuckovic<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'><o:p> </o:p></span></p></div></body></html>